Preclinical investigation of [149Tb]Tb-DOTATATE and [149Tb]Tb-DOTA-LM3 for tumor-targeted alpha therapy.
Mapanao AK, Busslinger SD, Mehta A, Kegler K, Favaretto C, Grundler PV, Talip Z, Köster U, Johnston K, Schibli R, van der Meulen NP, Müller C.
Mapanao AK, et al. Among authors: muller c.
Eur J Nucl Med Mol Imaging. 2025 Jan 2. doi: 10.1007/s00259-024-07035-8. Online ahead of print.
Eur J Nucl Med Mol Imaging. 2025.
PMID: 39743617